Business Context and Reporting Period
This Form 6-K filing by Lloyds Banking Group plc is dated March 11, 2016. The document serves as a notification under Listing Rule 9.6.14R regarding a corporate governance matter involving a Non-Executive Director.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a regulatory notification and does not contain financial performance data.
Material Changes
The filing announces that Deborah McWhinney, a Non-Executive Director of Lloyds Banking Group plc, will be appointed as a member of the Supervisory Board of Fresenius Medical Care AG & Co. KGaA. The appointment is effective from May 12, 2016, subject to shareholder approval at Fresenius Medical Care's Annual General Meeting on that date.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, management commentary on operations, or discussion of risks and contingencies. The only contingency noted is that Ms. McWhinney's appointment is subject to shareholder approval at the target company's Annual General Meeting.
Investor Verification Points
- Confirm the outcome of the Fresenius Medical Care AG & Co. KGaA Annual General Meeting on May 12, 2016, regarding the appointment of Deborah McWhinney.
- Verify if this appointment triggers any additional disclosure requirements or conflict of interest reviews under Lloyds Banking Group's internal governance policies.